scispace - formally typeset
E

Elliot B. Tapper

Researcher at University of Michigan

Publications -  304
Citations -  7880

Elliot B. Tapper is an academic researcher from University of Michigan. The author has contributed to research in topics: Medicine & Cirrhosis. The author has an hindex of 37, co-authored 241 publications receiving 4919 citations. Previous affiliations of Elliot B. Tapper include Harvard University & Brigham and Women's Hospital.

Papers
More filters
Journal ArticleDOI

Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study

Elliot B. Tapper, +1 more
- 18 Jul 2018 - 
TL;DR: Mortality due to cirrhosis has been increasing in the US since 2009, driven entirely by alcohol related liver disease, and people aged 25-34 have experienced the greatest relative increase in mortality.
Journal ArticleDOI

Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis

Andrew M. Moon, +3 more
- 01 Nov 2020 - 
TL;DR: Although vaccination, screening, and anti-viral treatment campaigns for hepatitis B and C have reduced CLD burden in some parts of the world, concomitant increases in injection drug use, alcohol misuse and metabolic syndrome threaten these trends.
Journal ArticleDOI

Use of Liver Imaging and Biopsy in Clinical Practice

Elliot B. Tapper, +1 more
- 23 Aug 2017 - 
TL;DR: Advances in imaging techniques such as vibration-controlled transientElastography and magnetic resonance elastography have reduced the need for liver biopsy as a means of diagnosing liver disease.
Journal ArticleDOI

Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores

George N. Ioannou, +11 more
- 01 Nov 2019 - 
TL;DR: Patients with cirrhosis before an SVR to treatment for HCV infection continue to have a high risk for HCC for many years, even if their FIB-4 score decreases, and should continue surveillance.
Journal ArticleDOI

Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.

Jennifer C. Lai, +6 more
- 01 Sep 2021 - 
TL;DR: The first American Association for the Study of Liver Diseases (AASLD) Practice Guidance on the management of malnutrition, frailty, and sarcopenia in patients with cirrhosis is presented in this paper.